Trial Profile
Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Pravastatin (Primary) ; Simvastatin (Primary) ; Valsartan (Primary)
- Indications Left ventricular hypertrophy
- Focus Therapeutic Use
- 16 Aug 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 20 Dec 2010 Actual end date (Aug 2010) added as reported by ClinicalTrials.gov.
- 20 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.